List of Covid 19 Vaccine Name
Table of Contents
Hey guys, If you are looking for the Covid-19 Vaccine Name List then you are at the right article. A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. The meaning of VACCINE is a preparation that is administered (as by injection) to stimulate the body’s immune response against a specific infectious agent or disease.
There are several COVID-19 vaccines validated for use by WHO. The first mass vaccination programme started in early December 2020 and the number of vaccination doses administered is updated on a daily basis on the COVID-19. Below you can check the complete list of Covid 19 Vaccine Name.
Covid-19 Vaccine Name List
7 Vaccines Approved for Use in India
| Vaccine Name | Approved in Country | Trials | Approval Source |
|---|---|---|---|
|
Zydus Cadila |
Approved in 1 country | 5 trials in 1 country | reuters.com |
| Moderna mRNA-1273 |
Approved in 83 countries | 35 trials in 9 countries | france24.com |
| Gamaleya Sputnik V |
Approved in 74 countries | 22 trials in 7 countries | pib.gov.in |
| Janssen (Johnson & Johnson) Ad26.COV2.S |
Approved in 95 countries | 16 trials in 18 countries | reuters.com |
| Oxford/AstraZeneca AZD1222 |
Approved in 134 countries | 52 trials in 23 countries | nytimes.com |
| Serum Institute of India Covishield (Oxford/AstraZeneca formulation) |
Approved in 47 countries | 2 trials in 1 country | cdsco.gov.in |
| Bharat Biotech Covaxin |
Approved in 12 countries | 7 trials in 1 country | bbc.com |
10 Vaccines Approved for Use by WHO
| Vaccine Name | Approved in countries | Trials | Approval Source | Type |
|---|---|---|---|---|
| Novavax NVX-CoV2373 |
Approved in 30 countries | 11 trials in 7 countries | extranet.who.int | Protein Subunit |
| Serum Institute of India COVOVAX (Novavax formulation) |
Approved in 2 countries | 2 trials in 1 country | extranet.who.int | Protein Subunit |
| Moderna mRNA-1273 |
Approved in 83 countries | 35 trials in 9 countries | extranet.who.int | Protein Subunit |
| Pfizer/BioNTech BNT162b2 |
Approved in 122 countries | 49 trials in 23 countries | extranet.who.int | RNA |
| Janssen (Johnson & Johnson) Ad26.COV2.S |
Approved in 95 countries | 16 trials in 18 countries | extranet.who.int | RNA |
| Oxford/AstraZeneca AZD1222 |
Approved in 134 countries | 52 trials in 23 countries | extranet.who.int | Non-Replicating Viral Vector |
| Serum Institute of India Covishield (Oxford/AstraZeneca formulation) |
Approved in 47 countries | 2 trials in 1 country | extranet.who.int | Non-Replicating Viral Vector |
| Bharat Biotech Covaxin |
Approved in 12 countries | 7 trials in 1 country | extranet.who.int | Non-Replicating Viral Vector |
| Sinopharm (Beijing) BBIBP-CorV (Vero Cells) |
Approved in 80 countries | 19 trials in 10 countries | extranet.who.int | Inactivated |
| Sinovac CoronaVac |
Approved in 48 countries | 28 trials in 8 countries | extranet.who.int | Inactivated |
14 Vaccines in Clinical Trials in India
| Vaccine Name | Approved in countries | Trials | Type |
|---|---|---|---|
| Novavax NVX-CoV2373 |
Approved in 30 countries | 11 trials in 7 countries | Protein Subunit |
| Serum Institute of India COVOVAX (Novavax formulation) |
Approved in 2 countries | 2 trials in 1 country | Protein Subunit |
| University Medical Center Groningen AKS-452 |
This vaccine has reached Phase 3 trials. | 4 trials in 2 countries | Protein Subunit |
| Zydus Cadila ZyCoV-D |
Approved in 1 country | 5 trials in 1 country | DNA |
| Gamaleya Sputnik V |
Approved in 74 countries | 22 trials in 7 countries | Non-Replicating Viral Vector |
| Oxford/AstraZeneca AZD1222 |
Approved in 134 countries | 52 trials in 23 countries | Non-Replicating Viral Vector |
| Serum Institute of India Covishield (Oxford/AstraZeneca formulation) |
Approved in 47 countries | 2 trials in 1 country | Non-Replicating Viral Vector |
| Bharat Biotech Covaxin |
Approved in 12 countries | 7 trials in 1 country | Inactivated |
| Biological E Limited BECOV2A |
This vaccine has reached Phase 2 trials. | 2 trials in 1 country | Protein Subunit |
| Biological E Limited BECOV2B |
This vaccine has reached Phase 2 trials. | 2 trials in 1 country | Protein Subunit |
| Biological E Limited BECOV2C |
This vaccine has reached Phase 2 trials. | 2 trials in 1 country | Protein Subunit |
| Biological E Limited BECOV2D |
This vaccine has reached Phase 2 trials. | 2 trials in 1 country | Protein Subunit |
| Gennova Biopharmaceuticals Limited HGCO19 |
This vaccine has reached Phase 2 trials. | 2 trials in 1 country | RNA |
| Bharat Biotech BBV154 |
This vaccine has reached Phase 1 trials. | 1 trial in 1 country | Non-Replicating Viral Vector |
As you know that there are 7 Vaccines Approved for Use in India, 10 Vaccines Approved for Use by WHO and 14 Vaccines in Clinical Trials in India. Therefore above we have listed Covid-19 Vaccine Name List for you. So if you want to know about those vaccines which are approved in most of the countries then you should stay on this list so that you can be aware of those vaccines that are really beneficial for the covid-19 patients.